Subsequently, similar observations were made for non-small cell lung cancer (NSCLC) and thyroid cancer (Linxweiler et al., 2012; Linxweiler et al., 2014) and SEC62 overexpression was linked to poor prognosis in NSCLC (Linxweiler et al., 2013). This evidence concerns the gene SEC62 and non-small cell lung carcinoma.